Healthcare Services

Poly Medicure Limited (POLYMED) Q3 FY23 Earnings Concall Transcript

● Feb 7, 2023

Poly Medicure Limited (NSE:POLYMED) Q3 FY23 Earnings Concall dated Feb. 06, 2023. Corporate Participants: Himanshu Baid — Managing Director Analysts: Rohan John — ICICI...

Mahindra Lifespace Developers Limited (MAHLIFE) Q3 FY23 Earnings Concall Transcript

● Feb 5, 2023

Mahindra Lifespace Developers Limited (NSE:MAHLIFE) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Arvind Subramanian — Managing Director and Chief...

Max Healthcare Institute Ltd (MAXHEALTH) Q3 FY23 Earnings Concall Transcript

● Feb 5, 2023

Max Healthcare Institute Ltd (NSE:MAXHEALTH) Q3 FY23 Earnings Concall dated Feb. 03, 2023.   Corporate Participants: Anoop Poojari — Client Manager –...

Dr Lal PathLabs Ltd Q3 FY23 Earnings Conference Call Insights

● Feb 3, 2023

Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY23 Earnings Concall Q&A Highlights: [00:12:28] Dheeresh Pathak from WhiteOak asked...

Dr. Lal PathLabs Limited Q3 FY23; Net Profit Down By 8%

● Feb 2, 2023

Dr. Lal PathLabs Limited (NSE: LALPATHLAB) reported a Revenue from Operations of ₹489.4 Crores, a decline of 1.5% from the...

Laurus Labs Limited (LAURUSLABS) Q3 FY23 Earnings Concall Transcript

● Jan 31, 2023

Laurus Labs Limited (NSE:LAURUSLABS) Q3 FY23 Earnings Concall dated Jan. 30, 2023. Corporate Participants: Satyanarayana Chava — Founder & Chief Executive Officer...

VIMTA LABS LTD (VIMTALABS) Q3 FY23 Earnings Concall Transcript

● Jan 30, 2023

VIMTA LABS LTD (NSE:VIMTALABS) Q3 FY23 Earnings Concall dated Jan. 30, 2023. Corporate Participants: Harita Vasireddi — Managing Director D.R. Narahai Naidu — Chief...

Jyothy Laboratories Limited (JYOTHYLAB) Q3 FY23 Earnings Concall Transcript

● Jan 26, 2023

Jyothy Laboratories Limited (NSE:JYOTHYLAB) Q3 FY23 Earnings Concall dated Jan. 25, 2023. Corporate Participants: Sanjay Agarwal — Chief Financial Officer M R...

Solara Active Pharma Sciences Limited (SOLARA) Q3 FY23 Earnings Concall Transcript

● Jan 26, 2023

Solara Active Pharma Sciences Limited (NSE:SOLARA) Q3 FY23 Earnings Concall dated Jan. 25, 2023. Corporate Participants: Abhishek Singhal — Investor Relations Consultant...

Apollo Hospitals: Ushering in a New Era

● Jan 9, 2023

“Our hospital business is on a very strong growth trajectory and will continue to grow. We will improve not only...